Researchers are exploring the potential for understanding and managing post-COVID symptoms by studying irritable bowel syndrome. Various studies and models are being examined, including the use of medical marijuana, ATH-063, and TL1A inhibitors, as well as the psychobiological model of gut-brain interaction. The exact causes and treatments of irritable bowel syndrome, and its possible connection to post-COVID symptoms, are still being investigated.